Editas Medicine, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $146.6M | $131.5M | $123.7M | $141.5M | $203.5M | $139.7M | $238.2M | $134.8M |
| Accounts Receivable | $15.2M | $16.3M | $10.2M | $5.1M | $267.0K | $6.0M | $418.0K | $30.0K |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $163.9M | $289.3M | $340.8M | $356.8M | $507.3M | $419.1M | $463.8M | $374.8M |
| Property, Plant & Equipment | $3.5M | $14.5M | $12.0M | $15.6M | $17.1M | $14.0M | $10.9M | $40.2M |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $186.5M | $341.6M | $499.2M | $514.3M | $677.5M | $572.6M | $508.9M | $420.4M |
| Liabilities | ||||||||
| Accounts Payable | $2.6M | $5.5M | $8.3M | $9.5M | $5.1M | $6.4M | $5.8M | $5.3M |
| Total Current Liabilities | $46.2M | $77.2M | $63.2M | $60.1M | $46.9M | $58.2M | $60.0M | $35.9M |
| Long-Term Debt | $53.6M | $52.4M | $0 | — | — | — | — | — |
| Total Liabilities | $159.2M | $207.3M | $150.1M | $153.6M | $123.8M | $179.0M | $246.4M | $184.2M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-1.63B | $-1.47B | $-1.23B | $-1.08B | $-857.7M | $-665.2M | $-549.2M | $-416.3M |
| Total Stockholders' Equity | $27.3M | $134.3M | $349.1M | $360.7M | $553.6M | $393.6M | $262.4M | $236.2M |